Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. (SLXNW) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SLXNW · as of Jun 8, 2026
Key Statistics
Explore Silexion Therapeutics Ltd. Data
slxnw stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
slxnw competitorsSLXNW
ACON
AKTX
DRMA
FOXO
PIIIStock Performance
Full HistoryAbout Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. Silexion Therapeutics LTD is a biopharmaceutical company focused on the discovery and development of RNA interference (RNAi)-based therapies and their delivery systems, specifically targeting aggressi…
what is silexion therapeutics ltd. · slxnw stock overview · silexion therapeutics ltd. company profile · who is silexion therapeutics ltd. ceo · slxnw NASDAQ · silexion therapeutics ltd. headquarters · silexion therapeutics ltd. business segments
About Stock Overview & Key Data
Silexion Therapeutics Ltd. (SLXNW) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 16, 2024. As of the latest trading session, SLXNW stock price is $0.03, with a market capitalization of $18,512. The stock has returned -48.84% over the past 12 months and +26.92% year-to-date.
In fiscal year 2025, Silexion Therapeutics Ltd. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Silexion Therapeutics Ltd. (SLXNW) stock price is $0.03. The stock is traded on NASDAQ under the ticker symbol SLXNW. The 52-week range is $0.03 – $0.10.